New trends in cannabis potency in USA and Europe during the last decade (2008–2017)

Potency of Δ9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology

(2018) David J. Potter et al.   Drug Testing and Analysis

Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands

(2018) Tom P. Freeman et al.   PSYCHOLOGICAL MEDICINE

A study of cannabis potency in France over a 25 years period (1992–2016)

(2017) Laurence Dujourdy et al.   FORENSIC SCIENCE INTERNATIONAL

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol

(2017) Douglas L Boggs et al.   NEUROPSYCHOPHARMACOLOGY

Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States

(2016) Mahmoud A. ElSohly et al.   BIOLOGICAL PSYCHIATRY

Phytocannabinoids: a unified critical inventory

(2016) Lumír Ondřej Hanuš et al.   NATURAL PRODUCT REPORTS

Keep off the grass? Cannabis, cognition and addiction

(2016) H. Valerie Curran et al.   NATURE REVIEWS NEUROSCIENCE

Cannabis potency: the need for global monitoring

(2015) T. P. Freeman et al.   ADDICTION

Examining the profile of high-potency cannabis and its association with severity of cannabis dependence

(2015) T. P. Freeman et al.   PSYCHOLOGICAL MEDICINE

Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study

(2014) Peggy van der Pol et al.   ADDICTION

Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

(2014) Tom P. Freeman et al.   ADDICTION

Cannabis potency in the Venice area (Italy): Update 2013

(2014) Luca Zamengo et al.   Drug Testing and Analysis

Understanding the risks associated with the use of new psychoactive substances (NPS): High variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products

(2014) Luca Zamengo et al.   TOXICOLOGY LETTERS

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

(2012) Amir Englund et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Potency Trends of Δ9-THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008*

(2010) Zlatko Mehmedic et al.   JOURNAL OF FORENSIC SCIENCES

Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

(2010) Celia JA Morgan et al.   NEUROPSYCHOPHARMACOLOGY

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Results of molecular analysis of an archaeological hemp (Cannabis sativa L.) DNA sample from North West China

(2008) Ashutosh Mukherjee et al.   GENETIC RESOURCES AND CROP EVOLUTION

Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology

(2008) David J. Potter et al.   JOURNAL OF FORENSIC SCIENCES

Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids

(2008) Lumír Ondřej Hanuš   MEDICINAL RESEARCH REVIEWS